Ardent Health Partners, LLC (ARDT) Free Cash Flow
Ardent Health Partners, LLC (ARDT) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$189.47M |
| 2023-12-31 | $84.29M |
| 2024-12-31 | $127.52M |
| 2025-12-31 | $258.61M |
How ARDT compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc. | $344.90M |
| EBS | Emergent BioSolutions Inc. | $156.80M |
| KURA | Kura Oncology Inc. | -$70.70M |
| IDYA | IDEAYA Biosciences Inc. | -$73.47M |
| AGEN | Agenus Inc. | -$77.20M |
These are five companies in the same sector as ARDT with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Ardent Health Partners, LLC Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("ARDT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARDT | $11.23 | -0.62% | 0.39M |
| 3 | ||||
| 4 | ||||
| 5 |